Integrated Biopharma (INBP) 0.0866 $INBP Vitamin

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Integrated Biopharma (INBP) 0.0866 $INBP

Vitamin Supplements Market Development and Demand Forecast to 2020 - Provides Information on the Historical and Current Market Size and the Future Potential of the Market
M2 - Thu Aug 20, 5:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6sjp3h/global_industry) has announced the addition of the "Global Industry Insight: Vitamin Supplements Market Development and Demand Forecast to 2020" report to their offering. The vitamin supplements market in the report includes vitamin supplements that are taken in different forms including capsule, pill, powder, granules, gel caps, tablet and liquid. The report includes the vitamin supplements offered by food and beverage, healthcare and personal care industry and consumed by adult women, adult men and elderly citizen. Global vitamin supplements market is increasing mainly attributed to growing consciousness among consumer about preventative healthcare. Healthcare spend is increasing with the increasing research and development (R&D) expenditure. Due to the increasing cost of healthcare, people are turning towards supplement products, including vitamin supplements, for a healthy life. Rising urban population paired with rise in educational qualification and rising number of health conscious people, especially in the developing Asian countries such as India and China, are more willing to shift towards intake of supplement products including vitamin supplements to compensate their nutritional requirement. Report Coverage: - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Provides information on the historical and current market size and the future potential of the market Key Topics Covered: 1 Research Scope and Methodology 2 Executive Summary 3 Market Outlook 4 Global Market Size and Forecasts (2010 - 2020) 5 Global Market Breakdown by End-User 6 Global Market Breakdown by Application 7 Global Market Breakdown by Region 8 Competitive Analysis and Market Share 9 Company Profiles Companies Mentioned - Archer Daniels Midland Company - BASF SE - Bayer AG - E.I. du Pont de Nemours and Company - Glanbia plc - Herbalife Ltd. - Integrated BioPharma, Inc - NBTY, Inc. - Nutraceutical International Corporation - Pharmavite LLC - Reckitt Benckiser Group plc - Royal DSM N.V. For more information visit http://www.researchandmarkets.com/research/6s...l_industry
HLF: 64.70 (-0.29), ADM: 43.63 (+0.16), NUTR: 25.57 (-0.14)

Global Market Study on Botanical Supplements 2014-2020 - Personal Care Segment to Witness Highest Growth in the $90 Billion Market
M2 - Wed Jul 08, 8:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mpw8qb/global_market) has announced the addition of the "Global Market Study on Botanical Supplements: Personal Care Segment to Witness Highest Growth by 2020" report to their offering. The global market for botanical supplements in value term grew from USD 45.1 billion in 2010 to USD 54.6 billion in 2013, and is expected to grow to USD 90.2 billion in 2020 growing at a CAGR of 7.5%. Also, Usage of botanical supplements by adult women (largest end user in 2013) is projected to increase to USD 32.9 billion in 2020 at a CAGR of 7.5%. Interest in healthy eating is influencing consumers to shift their dietary preferences in favour of food and food ingredients with potential health benefits. For consumers looking for a healthy lifestyle and seeking to reduce the risk of illness, herbal and botanical supplements (popularly known as herbal medicinal products) are among the best options. Botanical supplements include fresh or dried products in different forms, such as tablets, capsules, powders, and tea bags. Globally, garlic, ginger, santalum, plantago, ginseng, rhodiola extract, red clover extract, and soy extract are some of the most widely used botanical supplements. Increasing elderly population and little or no side effects of botanical supplements are expected to drive the global botanical supplements market. According to the Population Division of the United Nations Department of Economic and Social Affairs (UN-DESA), there were 841 million people aged 60 and above in 2013 compared to 205 million in 1950. The number is projected to reach over 2 billion by 2050. In the last few years, Europe has emerged as the largest market for botanical supplements, followed by Asia Pacific. In Asia Pacific, the long-standing tradition of using botanical medicine, the current economic development, and increasing urbanization are some factors driving the increasing demand for botanical supplements. Owing to these factors, Asia Pacific is expected to surpass Europe as the leading market for botanical supplements. The botanical supplements market is fragmented with several players operating at global or regional levels. The global botanical supplements market is highly fragmented, with top eight companies holding less than 40% market share. Ricola and Procter & Gamble are some of the major companies with global operations. Dabur operates mostly in India; however, the company started selling its products in the North American and European countries, such as the U.S., France, Germany and the U.K., recently. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porters Five Forces Analysis Chapter 4 Industry Overview Chapter 5 Market Size and Forecast, by Application Chapter 6 Market Size and Forecast, by End User Chapter 7 Market Size and Forecast, by Geography Chapter 8 Competitive Scenario Chapter 9 Company Profiles - BASF SE - Bayer AG - Bio-Botanica Inc. - Blackmores Limited - ChromaDex, Inc. - Integrated BioPharma, Inc. - NBTY, Inc. - NaturaLife Asia Co., Ltd. - Nutraceutical International Corporation - Pharmavite LLC - Procter & Gamble Company - Ricola AG - Surya Herbal, Ltd. - The Himalaya Drug Company For more information visit http://www.researchandmarkets.com/research/mp...bal_market
NUTR: 25.57 (-0.14), PG: 86.96 (+0.38)

Global Paclitaxel Industry Report 2015
M2 - Fri Jan 09, 6:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/p5l2qc/global_paclitaxel) has announced the addition of the "Global Paclitaxel Industry Report 2015" report to their offering. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Paclitaxel market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Paclitaxel industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on Paclitaxel industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Paclitaxel industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: Chapter One Paclitaxel Industry Overview Chapter Two Paclitaxel International and China Market Analysis Chapter Three Paclitaxel Technical Data and Manufacturing Plants Analysis Chapter Four Paclitaxel Production by Regions by Technology by Applications Chapter Five Paclitaxel Manufacturing Process and Cost Structure Chapter Six 2009-2014 Paclitaxel Productions Supply Sales Demand Market Status and Forecast Chapter Seven Paclitaxel Key Manufacturers Analysis Chapter Eight Up and Down Stream Industry Analysis Chapter Nine Paclitaxel Marketing Channels Analysis Chapter Ten 2015-2020 Paclitaxel Productions Supply Sales Demand Market Status and Forecast Chapter Eleven Paclitaxel Industry Development Proposals Chapter Twelve Paclitaxel New Project Investment Feasibility Analysis Chapter Thirteen Global and China Paclitaxel Industry Research Conclusions Companies Mentioned - Chongqin Meilian - Haiyao - Huiang - Jiangsu Yew Pharmaceutical Co, Ltd - Just From Natural - Sichuan Jiufeng - South Pharmaceutical - Taiji - Yunnan Hande Bio-Tech Co.,Ltd - Atlantis Bioactives - Indena - Mayne(Hospira) - Npi - Paxis(Integrated Biopharma) - Phyton - Phytogen - Roche Group - Weyerhaeser For more information visit http://www.researchandmarkets.com/research/p5...paclitaxel

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 5

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

17 Education & Technology Group Reports Second Quarter 2024 Results

Updated Category News Views 87

17 Education & Technology Group Reports Second Quarter 2024 Results 17 Education & Technology Group Inc. (NASDAQ: YQ) has recently shared its unaudited financial results for the second quarter of 2024, highlighting its ongoing dedication to enhancing educational technology and improving operational efficiency. Financial Highlights for Q2 2024 During the second quarter of...

Continue Reading
Axsome Therapeutics Unveils Q1 2025 Results with Live Discussion

Updated Category News Views 227

Axsome Therapeutics to Release First Quarter Financial Results NEW YORK, April 08, 2025 — Axsome Therapeutics, Inc. (NASDAQ: AXSM), an innovative biopharmaceutical company, is set to announce its financial performance for the first quarter of 2025. The announcement will take place before the U.S. financial markets open on May 5, 2025. Following this release, the...

Continue Reading
Medius Welcomes Chris Wilmot as Chief Financial Officer

Updated Category News Views 353

Medius Welcomes Chris Wilmot as Chief Financial Officer Medius, a prominent provider of Accounts Payable (AP) Automation and Spend Management solutions, has officially appointed Chris Wilmot to the position of Chief Financial Officer. This strategic appointment arrives during a crucial time of growth and innovation within the company. Chris Wilmot's Background and...

Continue Reading
KinderCare Learning Faces Legal Challenges Amid Care Neglect Claims

Updated Category News Views 279

KinderCare Learning Companies Faces Legal Scrutiny KinderCare Learning Companies, Inc. (NYSE: KLC) is currently under fire as investors have initiated a class action lawsuit amid severe allegations regarding child neglect within their facilities. The lawsuit, which seeks to represent those who purchased shares during their Initial Public Offering (IPO), indicates concerns...

Continue Reading
Uthana Announces Major Funding to Innovate 3D Animation with AI

Updated Category News Views 395

Uthana Secures Significant Funding for 3D Animation Innovation Uthana, a trailblazer in generative AI technology, recently announced a remarkable achievement in the world of funding. The company successfully secured $4.3 million, a significant milestone that positions it to transform the realm of 3D character animation. This funding was spearheaded by IA Ventures, with...

Continue Reading